The carcinogenic potential of RUNX2 overexpression and the possibility that its tumor suppressor functions are dysregulated suggest that the gain and amplification of chromosome 6p12-p21 plays a role in the etiology of osteosarcoma. Here, RUNX2 is linked to osteosarcoma.